Related references
Note: Only part of the references are listed.Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial
Aitana Juan-Giner et al.
LANCET (2021)
Minimal immune response to booster vaccination against Yellow Fever associated with pre-existing antibodies
Amandine Bovay et al.
VACCINE (2020)
Primary and secondary anti-viral response captured by the dynamics and phenotype of individual T cell clones
Anastasia A. Minervina et al.
ELIFE (2020)
Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine
Anna Z. Wec et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Helper-like Innate Lymphoid Cells in Humans and Mice
Sophie Guia et al.
TRENDS IN IMMUNOLOGY (2020)
Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protection
J. Erin Staples et al.
NPJ VACCINES (2020)
A Systematic, Unbiased Mapping of CD8(+)and CD4(+)T Cell Epitopes in Yellow Fever Vaccinees
Anette Stryhn et al.
FRONTIERS IN IMMUNOLOGY (2020)
Central memory CD8+ T cells derive from stem-like Tcf7hi effector cells in the absence of cytotoxic differentiation
Daniela Pais Ferreira et al.
IMMUNITY (2020)
Dynamic changes in circulating T follicular helper cell composition predict neutralising antibody responses after yellow fever vaccination
Johanna E. Huber et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2020)
Yellow fever vaccination for immunocompromised travellers: unjustified vaccination hesitancy?
Wesley de Jong et al.
JOURNAL OF TRAVEL MEDICINE (2019)
Long-term immunity against yellow fever in children vaccinated during infancy: a longitudinal cohort study
Cristina Domingo et al.
LANCET INFECTIOUS DISEASES (2019)
Immunogenicity and safety of fractional dose yellow fever vaccination: A systematic review and meta-analysis
Chukwudi A. Nnaji et al.
VACCINE (2019)
17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil
Ana Carolina Campi-Azevedo et al.
EMERGING INFECTIOUS DISEASES (2019)
The 17D-204 and 17DD yellow fever vaccines: an overview of major similarities and subtle differences
Clarissa de Castro Ferreira et al.
EXPERT REVIEW OF VACCINES (2018)
Duration of post-vaccination immunity to yellow fever in volunteers eight years after a dose-response study
Reinaldo de Menezes Martins et al.
VACCINE (2018)
Immature particles and capsid-free viral RNA produced by Yellow fever virus-infected cells stimulate plasmacytoid dendritic cells to secrete interferons
Laura Sinigaglia et al.
SCIENTIFIC REPORTS (2018)
Human TSCM cell dynamics in vivo are compatible with long-lived immunological memory and stemness
Pedro Costa del Amo et al.
PLOS BIOLOGY (2018)
Long-Term Protection After Fractional-Dose Yellow Fever Vaccination Follow-up Study of a Randomized, Controlled, Noninferiority Trial
Anna H. E. Roukens et al.
ANNALS OF INTERNAL MEDICINE (2018)
T cell receptor alpha variable 12-2 bias in the immunodominant response to Yellow fever virus
Amandine Bovay et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2018)
Human memory CD8 T cell effector potential is epigenetically preserved during in vivo homeostasis
Hossam A. Abdelsamed et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
A Systems Vaccinology Approach Reveals Temporal Transcriptomic Changes of Immune Responses to the Yellow Fever 17D Vaccine
Jue Hou et al.
JOURNAL OF IMMUNOLOGY (2017)
Origin and differentiation of human memory CD8 T cells after vaccination
Rama S. Akondy et al.
NATURE (2017)
Regulatory T cell frequencies and phenotypes following anti-viral vaccination
A. Charlotte M. T. de Wolf et al.
PLOS ONE (2017)
T Cell-Mediated Immunity towards Yellow Fever Virus and Useful Animal Models
Alan M. Watson et al.
VIRUSES-BASEL (2017)
Protein structure shapes immunodominance in the CD4 T cell response to yellow fever vaccination
Maximilian Koblischke et al.
SCIENTIFIC REPORTS (2017)
Live Attenuated Yellow Fever 17D Vaccine: A Legacy Vaccine Still Controlling Outbreaks In Modern Day
Natalie D. Collins et al.
CURRENT INFECTIOUS DISEASE REPORTS (2017)
Adaptive immune responses to booster vaccination against yellow fever virus are much reduced compared to those after primary vaccination
Michael Kongsgaard et al.
SCIENTIFIC REPORTS (2017)
Booster dose after 10 years is recommended following 17DD-YF primary vaccination
Ana Carolina Campi-Azevedo et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
17D yellow fever vaccine elicits comparable long-term immune responses in healthy individuals and immune-compromised patients
R. W. Wieten et al.
JOURNAL OF INFECTION (2016)
Adverse event reports following yellow fever vaccination, 2007-13
Nicole P. Lindsey et al.
JOURNAL OF TRAVEL MEDICINE (2016)
Comparison of the PRNT and an immune fluorescence assay in yellow fever vaccinees receiving immunosuppressive medication
Rosanne W. Wieten et al.
VACCINE (2016)
Animal models of yellow fever and their application in clinical research
Justin G. Julander
CURRENT OPINION IN VIROLOGY (2016)
Characterization of Yellow Fever Virus Infection of Human and Non-human Primate Antigen Presenting Cells and Their Interaction with CD4+ T Cells
Yu Cong et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
A Single 17D Yellow Fever Vaccination Provides Lifelong Immunity; Characterization of Yellow-Fever-Specific Neutralizing Antibody and T-Cell Responses after Vaccination
Rosanne W. Wieten et al.
PLOS ONE (2016)
The Human NK Cell Response to Yellow Fever Virus 17D Is Primarily Governed by NK Cell Differentiation Independently of NK Cell Education
Nicole Marquardt et al.
JOURNAL OF IMMUNOLOGY (2015)
A randomised double-blind clinical trial of two yellow fever vaccines prepared with substrains 17DD and 17D-213/77 in children nine-23 months old
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2015)
Initial viral load determines the magnitude of the human CD8 T cell response to yellow fever vaccination
Rama S. Akondy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Long-lasting stem cell-like memory CD8+ T cells with a naive-like profile upon yellow fever vaccination
Silvia A. Fuertes Marraco et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Serious adverse events associated with yellow fever vaccine
Reinaldo de Menezes Martins et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline
Ana Carolina Campi-Azevedo et al.
BMC INFECTIOUS DISEASES (2014)
Immune activation alters cellular and humoral responses to yellow fever 17D vaccine
Enoch Muyanja et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Monocytes and macrophages: developmental pathways and tissue homeostasis
Florent Ginhoux et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Review Article: Efficacy and Duration of Immunity after Yellow Fever Vaccination: Systematic Review on the Need for a Booster Every 10 Years
Eduardo Gotuzzo et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2013)
Lineage relationship of effector and memory T cells
Nicholas P. Restifo et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
Immunity to viruses: learning from successful human vaccines
Bali Pulendran et al.
IMMUNOLOGICAL REVIEWS (2013)
Temporal Dynamics of the Primary Human T Cell Response to Yellow Fever Virus 17D As It Matures from an Effector- to a Memory-Type Response
Kim Blom et al.
JOURNAL OF IMMUNOLOGY (2013)
Yellow Fever Vaccination Elicits Broad Functional CD4+ T Cell Responses That Recognize Structural and Nonstructural Proteins
Eddie A. James et al.
JOURNAL OF VIROLOGY (2013)
Living and dying for inflammation: neutrophils, eosinophils, basophils
Barbara Geering et al.
TRENDS IN IMMUNOLOGY (2013)
17DD yellow fever vaccine A double blind, randomized clinical trial of immunogenicity and safety on a dose-response study
Reinaldo M. Martins et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
T-Cell Memory Responses Elicited by Yellow Fever Vaccine are Targeted to Overlapping Epitopes Containing Multiple HLA-I and -II Binding Motifs
Andrea Barbosa de Melo et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Evaluation of accuracy and reliability of the plaque reduction neutralization test (micro-PRNT) in detection of yellow fever virus antibodies
Marisol Simoes et al.
BIOLOGICALS (2012)
The early cellular signatures of protective immunity induced by live viral vaccination
Siegfried Kohler et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
17DD and 17D-213/77 Yellow Fever Substrains Trigger a Balanced Cytokine Profile in Primary Vaccinated Children
Ana Carolina Campi-Azevedo et al.
PLOS ONE (2012)
Transcriptional control of effector and memory CD8+ T cell differentiation
Susan M. Kaech et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Cytokine Signatures of Innate and Adaptive Immunity in 17DD Yellow Fever Vaccinated Children and Its Association With the Level of Neutralizing Antibody
Maria Luiza-Silva et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Elderly Subjects Have a Delayed Antibody Response and Prolonged Viraemia following Yellow Fever Vaccination: A Prospective Controlled Cohort Study
Anna H. Roukens et al.
PLOS ONE (2011)
Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model
Justin G. Julander et al.
VACCINE (2011)
Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults
Maria Luiza Silva et al.
VACCINE (2011)
Reporting Rates of Yellow Fever Vaccine 17D or 17DD-Associated Serious Adverse Events in Pharmacovigilance Data Bases: Systematic Review
Roger E. Thomas et al.
CURRENT DRUG SAFETY (2011)
Yellow Fever Virus in Haemagogus leucocelaenus and Aedes serratus Mosquitoes, Southern Brazil, 2008
Jader da C. Cardoso et al.
EMERGING INFECTIOUS DISEASES (2010)
Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?
Alan D. T. Barrett et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response
Rama S. Akondy et al.
JOURNAL OF IMMUNOLOGY (2009)
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
Troy D. Querec et al.
NATURE IMMUNOLOGY (2009)
TLR expression and NK cell activation after human yellow fever vaccination
Patricia Cristina da Costa Neves et al.
VACCINE (2009)
Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology
Bali Pulendran
NATURE REVIEWS IMMUNOLOGY (2009)
Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines
Joseph D. Miller et al.
IMMUNITY (2008)
Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses
Denis Gaucher et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Immune response during adverse events after 17D-derived yellow fever vaccination in Europe
Hi-Gung Bae et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Case of yellow fever vaccine-associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes
Bali Pulendran et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
E protein domain III determinants of yellow fever virus 17D vaccine strain enhance binding to glycosaminoglycans, impede virus spread, and attenuate virulence
Eva Lee et al.
JOURNAL OF VIROLOGY (2008)
Intradermally Administered Yellow Fever Vaccine at Reduced Dose Induces a Protective Immune Response: A Randomized Controlled Non-Inferiority Trial
Anna H. Roukens et al.
PLOS ONE (2008)
Innate immunity phenotypic features point toward simultaneous raise of activation and modulation events following 17DD live attenuated yellow fever first-time vaccination
Marina Angela Martins et al.
VACCINE (2008)
Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease
Jon L. Belsher et al.
VACCINE (2007)
Early exposure to yellow fever vaccine during pregnancy
Denise P. Cavalcanti et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2007)
Activation/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first-time vaccination: is this the key to prevent severe adverse reactions following immunization?
M. A. Martins et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Neurologic disease associated with 17D-204 yellow fever vaccination: A report of 15 cases
Ann W. McMahon et al.
VACCINE (2007)
Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine
MJ Hepburn et al.
VACCINE (2006)
The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil
CES Suzano et al.
VACCINE (2006)
Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity
T Querec et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes
G Barba-Spaeth et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Lymphocyte subset analyses in healthy adults vaccinated with yellow fever 17DD virus
AP dos Santos et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2005)
A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys
F Guirakhoo et al.
JOURNAL OF VIROLOGY (2004)
Migration and differentiation of CD8+ T cells
W Weninger et al.
IMMUNOLOGICAL REVIEWS (2002)
Effector and memory T-cell differentiation: Implications for vaccine development
SM Kaech et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil
R Galler et al.
VIROLOGY (2001)
Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases
M Martin et al.
LANCET (2001)
Share Paper
